Reuters Health Report: December 26, 2017

Click to View in Browser Tuesday, December 26, 2017 Accurate celiac diagnosis in trial of new blood test (Reuters Health) - An experimental blood test accurately identifies people who do, or don't, have celiac disease, even if they are following gluten-free diets, researchers say. Peers may influence how well type 1 diabetes is managed (Reuters Health) - How young people with type 1 diabetes relate to their peers may have important effects on how well they manage the disease and how distressing it is for them, a small study suggests. Concussion protocol altered after recent missteps (Reuters) - The NFL's concussion protocol has been altered with late-season changes following recent incidents that have triggered investigations. Israel's Super-Pharm in talks to buy Teva Pharm plant: source TEL AVIV (Reuters) - Israel's largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries' plant in the coastal city of Ashdod, a source familiar with the matter said on Sunday, confirming media reports. Parental-notification law appears to limit, delay abortions (Reuters Health) - Minors had nearly one-third fewer abortions in an Illinois clinic in the year after the state enacted a parental-notification law, according to new research questioning the legislation's utility. Young gardeners eat more greens in first year at college (Reuters Health) - First-year college students who have gardening experience eat more fruits and vegetables while they're away at school compared with peers who don't have green thumbs, U.S. researchers say. Boston-area paramedics on front lines of U.S. opioid crisis (Reuters) - The paramedics find them everywhere - slumped over car steering wheels, barely breathing in doughnut shop bathrooms or dead in derelict apartments and expensive mansions. FDA rejects Agile's contraceptive patch, shares plunge (Reuters) - Agile Therapeutics Inc said on Friday the U.S. Food and Drug Administration declined to approve its contraceptive patch for the second time, sending the drug developer's shares down about 50 percent. U.S. judge tosses verdict against AbbVie in AndroGel case (Reuters) - A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. Kmart to pay $32 million to settle drug overbilling allegations WASHINGTON (Reuters) - Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Friday. Related Video MIT researchers invent device to save water-stressed plants Heavy rain triggers floodings in Northern Italy A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook